There's more evidence that two classes of inexpensive generic drugs reduce the risk of death in postmenopausal women with early breast cancer, a pair of new British studies find. The two classes of drugs -- called aromatase inhibitors and bisphosphonates -- can also be used together to increase the benefits and reduce some side effects, according to the authors of the studies published July 23 in The Lancet.
Read more: http://ift.tt/1IDEAlu
No comments:
Post a Comment